vs
Side-by-side financial comparison of Niagen Bioscience, Inc. (NAGE) and Regencell Bioscience Holdings Ltd (RGC). Click either name above to swap in a different company.
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.
Regencell Bioscience Holdings Ltd is a specialized bioscience enterprise focused on the research, development and commercialization of therapeutic products derived from traditional Chinese medicine. Its core pipeline targets neurodegenerative, immunological and infectious disease treatments, with primary operating markets across Greater China and other Asian regions.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $33.8M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $31.1M | — | ||
| Q1 25 | $30.5M | — | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $25.6M | — | ||
| Q2 24 | $22.7M | — | ||
| Q1 24 | $22.2M | — |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.6M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $5.1M | — | ||
| Q4 24 | $7.2M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $-15.0K | — | ||
| Q1 24 | $-492.0K | — |
| Q4 25 | 64.1% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 65.0% | — | ||
| Q1 25 | 63.4% | — | ||
| Q4 24 | 62.5% | — | ||
| Q3 24 | 63.5% | — | ||
| Q2 24 | 60.2% | — | ||
| Q1 24 | 60.7% | — |
| Q4 25 | 12.1% | — | ||
| Q3 25 | 12.5% | — | ||
| Q2 25 | 10.2% | — | ||
| Q1 25 | 15.7% | — | ||
| Q4 24 | 24.4% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -3.3% | — |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 13.5% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 16.6% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | -0.1% | — | ||
| Q1 24 | -2.2% | — |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $0.04 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $0.00 | — | ||
| Q1 24 | $-0.01 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
